Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Symbiotec Pharmalab Ltd

Symbiotec Pharmalab Ltd share price and stock overview

Symbiotec Pharmalab Ltd (NSE: SYMBIOTEC, BSE: 544889) operates in the Pharmaceuticals - Indian - Bulk Drugs & Formln sector. The stock has an ISIN of INE899I01028 and a face value of Rs 2. As of 02 October 2026, it trades at Rs (1,198.00) with a market capitalisation of Rs 7556.84 crore. Figures are live and subject to change.

Symbiotec Pharmalab Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln
NSE BSE
1,198.00 21.25 (1.81%) upARrowC
As on: 02-Oct-2026 , 03:55 AM
Market Cap(₹Cr) 7556.84
Book Value(₹Cr) 195.2322192
BSE Code : 544889 NSE Symbol : SYMBIOTEC EPS(TTM) : 24.26 ISIN Demat : INE899I01028 P/E(TTM) : 48.48 Face Value(₹) : 2 Div & Yield % : 0

Today Market

Stock Performance

Today Market

Today's High

72,572.90

Todday's Low

71,292.88

Open at

72,192.89

Previous Close

72,480.29

Volumes

Avg Price

-570.59

Historical Performance

News

12 Sep 26
Symbiotec Pharmalab shares were re-pledged to Beacon Trusteeship Limited for a debenture
Symbiotec Pharmalab Limited informed the BSE Limited and National Stock Exchange of India Limited on September 11, 2026, of re-created pledges of shares related to a debenture security agreement initially dated December 10, 2025.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
01-10-26 1194.00 1246.00 1161.10 1198.00 3713662 178464 4481002966.30 22421.95
30-09-26 1158.00 1196.80 1138.20 1176.75 2016189 100904 2369784601.45 22620.45
29-09-26 1051.00 1149.85 1045.05 1144.20 2887817 140033 3238598589.45 22716.20
28-09-26 1001.05 1074.95 1001.00 1055.75 1700556 77562 1787345860.80 22780.25
25-09-26 1023.00 1027.85 985.50 1003.35 675920 34253 678136596.00 23140.50
24-09-26 1061.05 1078.20 1015.10 1024.05 546818 33632 568236368.85 23063.10
23-09-26 1127.00 1128.20 1051.65 1062.00 1444410 72182 1557485743.00 23446.80
22-09-26 1099.00 1188.00 1095.00 1120.90 2182137 119944 2505481733.90 23329.00
21-09-26 1104.70 1171.00 1104.70 1156.05 1302847 69332 1494518987.20 23414.30
18-09-26 1050.00 1106.90 1048.00 1095.10 1099366 59275 1187730126.05 23346.40
123

Fundamentals

Company Valuation

Market Cap (₹cr)

7556.84

PE Ratio

48.48

PB Ratio

6.02

Dividend Yield

0

ROE

17.44

ROCE

20.81

Book Value (₹)

195.2322192

Face Value (₹)

2

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 9819885 15.28 9819885 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 6815730 10.61 6815730 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 4748208 7.39 4748208 3
Others 0 0.00 0 0
Sub Total 21383823 33.28 21383823 9
Total ShareHolding for Promoter & Group 21383823 33.28 21383823 9
plus   Publice Share Holding
plus  Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 11825492 18.40 11825492 3
Financial Institutions / Banks 1730057 2.69 1730057 37
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1718925 2.68 1718925 48
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 687156 1.07 687156 18
Mutual Funds / UTI 3558887 5.54 3558887 16
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 11706127 18.22 11706127 91
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 31226644 48.60 31226644 213
plus  Non Institution
Bodies Corporate 65517 0.10 65517 72
Clearing Members 0 0.00 0 0
Directors & their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 586927 0.91 586927 357
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 610198 0.95 610198 3
Individuals holding nominal share capital up to Rs. 1 lakh 10056648 15.65 10056648 427052
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 82695 0.13 82695 2
Sub Total 11645645 18.12 11645645 427508
Total Public Shareholding 42872289 66.72 42872289 427721
Total of Promoter & Public ShareHolding 64256112 100.00 64256112 427730
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 64256112 100.00 64256112 427730

Financials (₹ in cr)

Consolidated Standalone
Year EndMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Net Sales869.15751.55716.25566.51681.80
OPM (%)18.6819.5618.486.9415.47
OP162.36146.98132.3539.34105.47
Other Income3.114.437.096.463.00
PBIDT231.97206.11178.4175.33133.27
INTEREST25.3316.047.247.461.97
PBDT206.65190.08171.1767.87131.29
PBT144.37146.98132.3539.34105.47
EO-8.990.000.000.000.00
PBT after EO153.36146.98132.3539.34105.47
TAXES43.4650.1930.9314.7828.18
PAT109.8896.78100.0623.4977.53
EPS19.0017.3691.4921.4871.00
Raw Material34.7637.9943.6554.4452.52
Power and Fuel4.803.944.355.074.04
Employee Cost17.7616.2714.5316.6112.27
Other Manufacturing Expenses0.000.000.000.000.00
Selling and Administration Expenses4.484.663.755.105.39
Miscellaneous Expenses2.031.672.673.453.53
Revenue (Growth %) 15.654.9326.43-16.917.73
PBIDT (Growth %)12.5515.53136.85-43.48-33.66
PAT (Growth %) 13.53-3.27326.02-69.71-37.11
PBIDT (Margin %)26.6927.4224.9113.3019.55
PAT (Margin %) 12.6412.8813.974.1511.37

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Share Capital 10.9410.9410.9410.9410.9410.94
Reserves Total 899.85750.20661.88684.25622.42486.90
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds910.79761.14672.82695.19633.36497.84
Secured Loans 292.5251.72107.2763.5947.42117.50
Unsecured Loans 0.000.000.000.000.003.19
Total Debt292.5251.72107.2763.5947.42120.69
Other Liabilities15.4112.367.136.675.995.30
Total Liabilities1218.72825.22787.22765.45686.77623.83
APPLICATION OF FUNDS :
Gross Block 544.84513.66418.24391.57348.52309.01
Less : Accumulated Depreciation 227.77189.84152.59125.49100.9479.40
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 317.07323.82265.65266.08247.58229.61
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress59.0519.3673.9022.6226.7330.50
Producing Properties0.000.000.000.000.000.00
Investments 44.2042.2565.60130.17122.59110.39
Current Assets, Loans & Advances
Inventories 254.03332.61241.72245.41225.26230.85
Sundry Debtors 175.98125.43112.31143.66118.69106.92
Cash and Bank Balance22.596.272.836.3241.1428.54
Loans and Advances 26.6333.9829.7620.2426.9421.51
Total Current Assets479.23498.29386.62415.62412.03387.82
Less : Current Liabilities and Provisions
Current Liabilities 96.34244.86102.36103.36127.56126.64
Provisions 11.983.205.975.948.033.70
Total Current Liabilities & Provisions108.32248.07108.33109.30135.59130.34
Net Current Assets370.91250.23278.29306.32276.44257.48
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets0.916.030.000.000.002.59
Deferred Tax Liability21.9919.9419.5719.7519.5117.99
Net Deferred Tax-21.08-13.91-19.57-19.75-19.51-15.40
Other Assets448.58203.47123.3559.9932.9511.24
Total Assets1218.73825.22787.22765.43686.78623.82
Contingent Liabilities0.000.000.710.000.000.87

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Financing Activities -79.0414.7336.53-62.98224.81
Investing Activities -78.99-33.94-132.50-80.80-291.79
Net Cash Flow -0.334.41-2.623.6716.31
Operating Activities 157.7023.6293.35147.4683.29

Peers

Balance Sheet Financial Ratios Profit & Loss
Aarti Pharmalabs...

968.50

(+1.55%)
Accent Microcell...

669.90

(-0.70%)
Accretion Pharma...

203.30

(-5.00%)
Achyut Healthcar...

Advanced Enzyme ...

274.25

(-2.61%)
Akums Drugs & Ph...

813.10

(-0.66%)
Albert David Ltd

856.70

(-1.78%)
Alembic Pharmace...

815.25

(-1.24%)

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
AKS
ANIL KUMAR SATWANI
Chairman / Executive Director / M D / Promoter
Executive
Independent Directors
SK
Sunita Kishnani
Independent Non Exe. Director
Ind.
PP
PRATIK PATEL
Independent Non Exe. Director
Ind.
PK
Pramod Kasat
Independent Non Exe. Director
Ind.
Nominee Directors
RBM
ROHIT BRIJMOHAN MANTRI
Nominee
Nom.
DNM
Dhananjay N Mungale
Nominee
Nom.
Other Officials
SJ
Salil Jain
Company Sec. & Compli. Officer
Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Symbiotec Pharmalab Ltd? −

Symbiotec Pharmalab Ltd trades on NSE under SYMBIOTEC and on BSE under code 544889. The ISIN is INE899I01028 and the face value is Rs 2.

What is the share price of Symbiotec Pharmalab Ltd today? +

As of 02 October 2026, Symbiotec Pharmalab Ltd trades at Rs 1,198.00, a change of 21.25 (1.81%) on the day. Prices are live and subject to change.

What is the market capitalisation of Symbiotec Pharmalab Ltd? +

As of 02 October 2026, Symbiotec Pharmalab Ltd has a market cap of about Rs 7556.84 crore. This figure is live and moves with the share price.

Is Symbiotec Pharmalab Ltd profitable? +

In March 2026, Symbiotec Pharmalab Ltd reported a profit after tax of Rs 109.88 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Symbiotec Pharmalab Ltd? +

: As of 02 October 2026, the PE (TTM) for Symbiotec Pharmalab Ltd is 48.48 and the price-to-book ratio is 6.02. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Symbiotec Pharmalab Ltd pay a dividend? +

As of 02 October 2026, the dividend yield for Symbiotec Pharmalab Ltd is 0%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Symbiotec Pharmalab Ltd? +

As of the latest disclosed pattern, promoters hold 33.28% of Symbiotec Pharmalab Ltd. Public shareholding is 66.72%, including mutual funds at 5.54% and foreign institutional investors at 2.68%.

What were the latest annual financials of Symbiotec Pharmalab Ltd? +

In March 2026, Symbiotec Pharmalab Ltd reported net sales of Rs 869.15 crore, revenue growth of 15.65%, and earnings per share of Rs 19.00.